Hepatitis C in African Americans: summary of a workshop.
Howell
C
C
Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. Chowell@umaryland.edu
Jeffers
L
L
Hoofnagle
J H
JH
D001741:Black or African American / Q000706:statistics & numerical data*; D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000821:virology; D019698:Hepatitis C, Chronic / Q000453:epidemiology* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D015994:Incidence; D007372:Interferons / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000453:epidemiology / Q000821:virology; D016031:Liver Transplantation; D015995:Prevalence; D012254:Ribavirin / Q000627:therapeutic use; D015819:Substance Abuse, Intravenous / Q000150:complications; D014481:United States; D014728:Veterans / Q000706:statistics & numerical data
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons